Withi
Within the newest buying and selling session, AbbVie (ABBV) closed at $85.62, marking a +0.23% transfer from the day past. This transformation outpaced the S&P 500’s 3.17% loss on the day. On the identical time, the Dow misplaced 3.77%, and the tech-heavy Nasdaq misplaced 2.28%.
Coming into at the moment, shares of the drugmaker had gained 4.45% up to now month. In that very same time, the Medical sector misplaced 6.35%, whereas the S&P 500 misplaced 8.05%.
ABBV will likely be trying to show energy because it nears its subsequent earnings launch. In that report, analysts count on ABBV to put up earnings of $2.25 per share. This is able to mark year-over-year progress of 5.14%. In the meantime, our newest consensus estimate is asking for income of $8.35 billion, up 6.69% from the prior-year quarter.
Trying on the full 12 months, our Zacks Consensus Estimates recommend analysts expect earnings of $10.53 per share and income of $47.88 billion. These totals would mark modifications of +17.79% and +43.93%, respectively, from final 12 months.
…